Search by ticker code:
Generic filters

Search by ticker code:
Generic filters

Search by ticker code:
Generic filters

3 ASX Health Care Shares Paying Healthy Dividends

Low interest rates have made it impossible to generate a reasonable income from bank accounts and term deposits. So, here are three health care companies paying big dividends right now.

Regis Healthcare Ltd (ASX: REG)

Regis Healthcare is one of Australia’s largest providers of aged care services with more than 6,000 residents calling Regis home. Across Australia, Regis owns and operates 63 aged care facilities that offer a range of healthcare support services including respite care, specialist dementia care and palliative care.

The Regis share price has fallen recently following its FY19 results, which showed the company was impacted by the recent aged care Royal Commission. Regis reported an 18% cut to dividends but the shares still trade on a fully-franked trailing dividend yield of 5.56%.

The Rask Finance video below explains dividends:

Although the dividend looks attractive now, the question is whether dividends can be maintained with FY20 results also expected to be impacted by the Royal Commission. I don’t know if I would buy today, but this is one company worth watching.

Estia Health Ltd (ASX: EHE)

Estia Health is a competitor of Regis and has been an aged care provider in Australia for nearly 50 years. The company currently operates 69 facilities across Australia.

Estia Health fared better than Regis in its FY19 result, reporting 7% revenue growth and net profit after tax (NPAT) in-line with the FY18 result. Importantly, Estia also reported a higher occupancy rate than Regis across its centres (93.6% versus 92.7%).

Estia managed to maintain its fully-franked dividend of 15.8 cents per share for the year, giving shares a trailing dividend yield of 6.08%.

Comparing Regis and Estia, my pick would have to be Estia right now.

Australian Pharmaceutical Industries Ltd (ASX: API)

Moving away from aged care, Australian Pharmaceuticals Industries is the parent company of Priceline Pharmacy, Soul Pattinson Chemist and Pharmacist Advice. Services provided by API include wholesale product delivery, retail services, marketing programs and business advisory services.

API reported modest growth in 1H19, with gross profit up 9.5% despite a 1.6% decline in revenue. Earnings before interest and tax (EBIT) grew by 5.8% and the fully-franked interim dividend was increased from 3.5 cents per share to 3.75 cps.

At the current share price, API shares provide a trailing dividend yield of 5.98%.

My Take

These dividend yields of around 6% are difficult to find on the ASX and typically come from banks. These three companies, although they have faced some challenges over the past year, all have growth opportunities with a growing and ageing population. Pleasingly, Estia and API, in particular, look like they will be able to maintain current dividends.

There are certainly risks to consider, especially around the impacts of the Royal Commission for Regis and Estia, but these are three companies that I think could be worth considering for their dividends.

For more proven dividend companies, have a look at the free report below.

[ls_content_block id=”14945″ para=”paragraphs”]

Disclosure: At the time of writing, Max does not own shares in any of the companies mentioned.

$50,000 per year in passive income from shares? Yes, please!

With interest rates UP, now could be one of the best times to start earning passive income from a portfolio. Imagine earning 4%, 5% — or more — in dividend passive income from the best shares, LICs, or ETFs… it’s like magic.

So how do the best investors do it?

Chief Investment Officer Owen Rask has just released his brand new passive income report. Owen has outlined 10 of his favourite ETFs and shares to watch, his rules for passive income investing, why he would buy ETFs before LICs and more.

You can INSTANTLY access Owen’s report for FREE by CLICKING HERE NOW and creating a 100% FREE Rask Account.

(Psst. By creating a free Rask account, you’ll also get access to 15+ online courses, 1,000+ podcasts, invites to events, a weekly value investing newsletter and more!)

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.

Information warning: The information on this website is published by The Rask Group Pty Ltd (ABN: 36 622 810 995) is limited to factual information or (at most) general financial advice only. That means, the information and advice does not take into account your objectives, financial situation or needs. It is not specific to you, your needs, goals or objectives. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. In addition, you should obtain and read the product disclosure statement (PDS) before making a decision to acquire a financial product. Please read our Terms and Conditions and Financial Services Guide before using this website. The Rask Group Pty Ltd is a Corporate Authorised Representative (#1280930) of AFSL #383169.

Skip to content